Principales Publicaciones

– Zhang G, Lehmann HC, Manoharan S, Hashmi M, Shim S, Ming GL, Schnaar RL, Lopez PH, Bogdanova N, Sheikh KA (2011). J Neurosci 31(5):1664-1675.

– Lopez PH, Ahmad AS, Mehta NR, Toner M, Rowland EA, Zhang J, Doré S, Schnaar RL (2011). J Neurochem. 116(5):900-908.

– Lopez PH, Zhang G, Zhang J, Lehmann HC, Griffin JW, Schnaar RL, Sheikh KA (2010). J Neurosci. 30(28):9533-41.

– Schnaar RL, Lopez PH. Myelin-associated glycoprotein and its axonal receptors (2009). J Neurosci Res.; 87:3267-76. Mini-Review.

– Lopez PHand Schnaar RL. Gangliosides in cell recognition and membrane protein regulation (2009). Current opinion in Structural Biology; 19: 549-57.

– Lopez PH, Zhang G, Bianchet MA, Schnaar RL, Sheikh KA. Structural requirements of anti-GD1a antibodies determine their target specificity (2008) Brain 131:1926-39.

– Singer HS, Gause C, Morris C, Lopez PH; Tourette Síndrome Study Group.Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychatric disorders associated with streptococcal infections (2008) Pediatrics 121 (6): 1198-205.

– Mehta NR, Lopez PH, Vyas AA, Schnaar RL (2007) Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J Biol Chem. 282: 27875-86.

– Lopez PH*, Lehmann HC*, Zhang G, Ngyuen T, Zhang J, Kieseier BC, Mori S, Sheikh KA (2007). Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci 27: 27-34. * Ambos autores deben ser considerados primer autor.

– Comín R, Yuki N, Lopez PH, Nores GA (2006) High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy. J Neurosci Res 84: 1085-90.

– Zhang G, Lopez PH, Sheikh KA (2006) Comparison of different brands of IVIg in an in vitro model of immune neuropathy. J Neuroimmunol 173: 200-3.

– Lopez PH, Schnaar R.L (2006) Determination of glycolipid-protein interaction specificity. Methods Enzymol.; 417:205-20. Review.

– Lopez PH, Comín R, Villa AM, Di Egidio M, Saizar RD, Sica RE, Nores GA (2006) A new type of anti-ganglioside antibodies present in neurological patients. Biochim Biophys Acta 1762: 357-61.

– Vilcaes AA, Degano AL, López PH, Nores GA, Roth GA (2005) Antibodies which block anti-myelin basic protein antibodies associated with development of experimental autoimmune encephalomyelitis in Wistar rats. J Neuroimmunol 164: 31-6.

– Zhang G, Lopez PH, Li CY, Mehta NR, Griffin JW, Schnaar RL, Sheikh KA (2004) Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain 127: 1085-100.

– Villa AM, López PH, Sevlever G, Nores GA, Sica RE (2002) Antiganglioside antibodies in serum of patients with chronic sensory ataxic neuropathy. Medicina (B Aires) 62: 237-40.

– Lopez PH, Villa AM, Sica RE, Nores GA (2002) High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies. J Neuroimmunol 128: 69-76.

– Lopez PH, Lardone RD, Irazoqui FJ, Maccioni M, Nores GA (2002). The origin of anti-GM1 antibodies in neuropathies: the “binding site drift” hypothesis. Neurochem Res. 27 (7-8):687-95. Review.

– Irazoqui FJ, Lopez PH, Mandel U, Nores GA(2002) Influence of terminal residue on adjacent disaccharide immunogenicity. Mol Immunol 38: 825-31

– Lopez PH, Lardone RD, Irazoqui FJ, Villa AM, Di Egidio M, Saizar RD, Sica RE, Nores GA (2001) Variable patterns of anti-GM (1) IgM-antibody populations defined by affinity and fine specificity in patients with motor syndromes: evidence for their random origin. J Neuroimmunol 119: 131-6.

– Lopez PH, Degano AL, Monferran CG, Irazoqui FJ, Nores GA, Roth GA (2001) Time course of IgM antibodies which block anti-myelin basic protein IgG antibodies associated with development of experimental autoimmune encephalomyelitis in rabbits. J Neuroimmunol 119: 30-6.

– Irazoqui FJ, Jansson B, Lopez PH, Nores GA (2001) Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation. J Biochem 130: 33-7.

– Irazoqui FJ, Lopez PH, Vides MA, Nores GA (2000) Novel immunogenicity of Thomsen-Friedenreich disaccharide obtained by a molecular rotation on its carrier linkage. Glycobiology 10: 781-7.

– Lopez PH, Irazoqui FJ, Nores GA (2000) Normal human plasma contains antibodies that specifically block neuropathy-associated human anti-GM1 IgG-antibodies. J Neuroimmunol 105: 179-83.

– Kremer DM, López PH, Mizutamari RK, Kremer LJ, Bacile EA, Nores GA (1997) Factors defining target specificity in antibody-mediated neuropathy: density-dependent binding of anti-GD1a polyclonal IgG from a neurological patient. J Neurosci Res 47: 636-41.